Cosmos.
Ulam raja leaf is a raw salad green in Malaysia and Indonesia, and in a capsule it is a concentrated source of quercetin, kaempferol and chlorogenic acid.
- Category
- Herb
What Cosmos is, and what it does.
- Does it work
- It suits people who eat few fresh vegetables and want a leafy polyphenol source, and formulators building a plant-based antioxidant blend around a named single leaf.
- How much to take
- No daily amount is on record, so we won't put a figure on it. As a food it goes in the bowl by the handful, and capsules concentrate the same dried leaf.
- Time to feel it
- Polyphenol intake registers on markers of oxidative stress over weeks rather than as a same-day sensation, so this one is read on a panel rather than by feel.
- The first dose
- Day one passes without a signal. What's happening is absorption and conjugation of the flavonols, which only shows up on a blood measurement.
- With regular use
- Weeks of daily leaf keep a steady trickle of conjugated flavonol metabolites in circulation, and the chlorogenic acid reaches your colon bacteria. Both are measured, not felt.
- How well tolerated
- Eaten as an everyday vegetable across Southeast Asia and well tolerated. Its polyphenols bind non-heme iron, so take an iron supplement a couple of hours apart.
- How it feels
- Grassy and slightly bitter as a tea or powder. No stimulation and no sedation. The experience sits closer to eating a vegetable than to taking something.
- The overlooked benefit
- Chlorogenic acid mostly skips the small intestine and lands in your colon, where bacteria release caffeic acid. How much you get depends on which bacteria you happen to carry.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Antioxidant capacity of the leaf's flavonolsIn vitro study
- Dietary polyphenol content of the fresh leafNarrative review
- Healthy glucose metabolismAnimal study
- Bone strengthAnimal study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Flavonols such as quercetin become radicals themselves once they quench a radical. Ascorbate can hand an electron back and regenerate the intact flavonol, so the two behave as a pair rather than as two separate additions. This is bench chemistry and cell-level work, not a demonstrated human outcome. The pairing also reflects how the leaf is normally eaten, alongside other raw vegetables.
Polyphenol-dense plant material binds non-heme iron and reduces how much of it crosses the intestinal wall. Anyone taking a non-heme iron supplement for low iron status has a straightforward reason to separate the two by a couple of hours. The effect is on the iron, not on the leaf, and it does not apply to heme iron from meat.
Taking both means the same aglycone arrives from two directions, one as a food matrix glycoside and one as a concentrated isolate. Absorption differs by source, because the sugar attached to the glycoside decides which hydrolysis route runs first. Stacking them is duplication rather than complementarity, which matters if a formulator is counting total flavonol load.
Divalent minerals form complexes with phenolic hydroxyl groups and with phytate in the same matrix, lowering the fraction available for uptake. The practical answer is timing, not avoidance. Nothing here changes if the leaf is taken away from the mineral dose.
Tocopherol works inside the lipid bilayer while flavonol metabolites sit largely in the aqueous phase and at the membrane surface. The two cover different territory, and flavonoids can participate in returning the tocopheroxyl radical to tocopherol. That regeneration loop is well described in model systems. Whether it produces a measurable difference in a person taking both has not been shown.
Both supply large amounts of substrate for the same UGT and SULT conjugation enzymes in the gut wall and liver. When those enzymes are loaded, conjugation of one polyphenol slows and more unconjugated material gets through, which raises exposure in a way that is hard to predict from either product's label. Formulators stacking several polyphenol extracts should count the total phenolic load, not the individual doses.
Piperine slows glucuronidation, which is the main clearance route for flavonol aglycones. Adding it raises circulating levels of the polyphenol rather than changing what the polyphenol does. That is a pharmacokinetic effect and it works in both directions, so it also raises exposure to anything else in the formula that clears by the same route.
A large share of the leaf's phenolics reaches the colon intact and only becomes absorbable after bacterial esterases and glycosidases cut them apart. The metabolites produced depend on which organisms are present, which is one reason polyphenol responses vary so much between people. Whether adding a defined probiotic strain shifts that conversion in a useful direction has not been established in humans.
Nothing specific on file for Cosmos. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Cosmos actually does.
The leaf's main compounds are quercetin and kaempferol glycosides plus chlorogenic acid and related forms. These are polyphenols with well-characterised radical-scavenging chemistry in the lab, meaning they donate hydrogen atoms to neutralise fat and oxygen radicals.
These flavonoid compounds aren't absorbed intact, gut and bacterial enzymes strip off the sugar first, and what's left gets modified in the gut wall and liver, so what circulates in blood is almost entirely a modified metabolite, not the original leaf compound.
Chlorogenic acid mostly reaches the colon rather than being absorbed in the small intestine, where gut bacteria break it into two smaller acids, so any downstream activity depends on that bacterial step, which differs from person to person.
The flavonoid compounds in this leaf bind non-heme iron in the gut and form complexes the body absorbs poorly, ordinary chemistry that applies to any polyphenol-rich plant eaten alongside an iron source.
Where Cosmos comes from.
A leafy herb eaten raw as a salad green across Malaysia and Indonesia, where it is called ulam raja. What ends up in a capsule is the dried leaf, or a concentrated extract of it. The interesting chemistry is the same family of plant pigments found in onions, apples and tea.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Harvested before flowering, when flavonol glycoside content in the leaf is highest.
Shade or low-temperature air drying. High heat degrades the caffeoylquinic acids and darkens the powder.
Water or 50 to 80 percent ethanol pulls the flavonol glycosides and chlorogenic acids. Water-only extracts skew toward the more polar glycosides.
Batches are typically assayed by HPLC against quercetin or rutin and declared as total flavonoid content.
Encapsulated powder, spray-dried extract on a maltodextrin carrier, or a tea-cut for infusion.
The forms it comes in.
The essence, in one line each.
- Cosmos caudatus supplementation combined with aerobic exercise altered selected neurobehavioural measures and biochemical profile readouts compared with control in the study model.Animal study. Joseph DK et al., 2026 (PLoS One). PMID 42418535 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Cosmos. The full linked list is below.
The studies, linked.
9 sources behind our Cosmos verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialCopeptin as a Novel Diagnostic and Prognostic Marker in the Management of Neurological and Neurosurgical Patients With Sodium Imbalance The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)ClinicalTrials.gov ↗469 participants, Completed
- Clinical trialCOSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal GelClinicalTrials.gov ↗412 participants, Completed
- Clinical trialConstitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)ClinicalTrials.gov ↗93 participants, Terminated
- Clinical trialComputerised Cognitive Behavioural Therapy for Treatment of Depression in MS (CoSMoS): Clinical Trial Pilot StudyClinicalTrials.gov ↗24 participants, Completed
- Clinical trialOxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On StudyClinicalTrials.gov ↗10 participants, Completed
- Clinical trialThe Use of the PCI Wide Field Imaging System for Pediatric Ophthalmic Photography of the Posterior and Peripheral RetinaClinicalTrials.gov ↗6 participants, Terminated
- Clinical trialReal-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic CosmosClinicalTrials.gov ↗293,334 participants, Active not recruiting
- Clinical trialCataract and AMD in a Trial of a Multivitamin and Cocoa Extract (COSMOS-Eye)ClinicalTrials.gov ↗Phase 4, 21,442 participants, Unknown
- Clinical trialComparison of Electromyographic Threshold and Dynamic Balance After Single Leg Cycling Ergometer and Double Leg Cycling Ergometer Training in Healthy AdultsClinicalTrials.gov ↗32 participants, Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.